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1104-191 Nicotine Administration Significantly Alters Peripheral, 
Bone Marrow and Splenic Stem Cell Populations in C57/
Bl6 Mice
Edwin Chang, Bingyin Wang, Camilla Forsberg, Rich Allsopp, Irving L. Weissman, John 
Cooke, Stanford University, School of Medicine, Stanford, CA
Background:Smoking is known to increase circulatory mononuclear cell counts. Nico-
tine is a major component of cigarette smoke. Recently, it has been reported that nicotine
promotes tumor growth, plaque neovascularization and wound healing through its intrin-
sic angiogenic properties. We investigated the potential connections between nicotine’s
angiogenic and its hematopoeitic or lymphopoeitic properties.
Hypothesis: That nicotine can promote angiogenesis partly through its capacity to elicit
the proliferation or mobilization of peripheral cells via the activation, proliferation and
migration of hematopoeitic stem cells (HSC) and endothelial precursor cells (EPCs)
Method: C57/Bl6 mice (n=10) were fed normal mouse chow plus 100ug/ml free base nic-
otine/0.4% saccharine. Control mice (n=10) were given normal chow and 0.4% saccha-
rine ad libitum. At 2-weeks (n=5) and at 6 weeks (n=5), the animals were sacrificed and
their peripheral blood, bone marrow and spleen harvested. Total cell counts for peripheral
cells, bone marrow and spleen as well as splenic weight were recorded. Isolated bone
marrow, splenocytes and pooled mononuclear blood cells were assessed for HSC and
EPC population via FACS analysis. Statistical analyses based upon Student’s t-test.
Results Nicotine treated animals had significantly increased mass of spleen (p<0.01)
and an elevated white blood cell count (p<0.02) after six weeks. Total cell numbers of
bone marrow and spleen were also significantly increased (p<0.02) in the nicotine fed
mice. No significant change in body mass was evident. FACS analysis of the bone mar-
row and spleen showed a small augmentation (p<0.04) of splenic CD8 levels at 2 and 6
weeks of ad libitum nicotine administration. Otherwise, no major changes in the cellular
subpopulations of nicotine-challenged bone marrow or spleen were observed. Nicotine
did significantly increase (p<0.03) HSC and EPC levels in nicotine treated tissue.
Conclusions: Nicotine’s capability to increase bone marrow HSC and EPC levels may
serve as a functional link for both nicotine’s angiogenic properties and its putative role in
augmenting circulatory mononuclear cell content.
1104-192 Heterologous Transplantation of CD34+ Cells From 
Patients With Coronary Ischemia Leads to Myocardial 
Salvage and Enhanced Functional Recovery in Murine 
Model of Myocardial Infarction
Larry J. Diaz-Sandoval, Atsuhiko Kawamoto, Young-Sup Yoon, Toshinori Murayama, 
Kengo Kusano, Marianne Kearney, Oren Tepper, Takayuky Asahara, Jeffrey M. Isner, 
Douglas W. Losordo, St. Elizabeth's Medical Center, Boston, MA
Background: CD34+ cells (CDCs) contain an enriched fraction of endothelial progenitor
cells. When obtained from healthy volunteers, they can induce neovascularization in
models of myocardial infarction (MI). It is unknown whether coronary ischemia impairs
the function of these cells. We investigated the hypothesis that administration of CDCs
from patients with coronary ischemia could induce therapeutic myocardial neovascular-
ization.
Methods: Mononuclear cells (MNCs) and CDCs were isolated from peripheral blood
samples of healthy volunteers (n=5) and patients with positive stress test undergoing car-
diac catheterization (n=7). After 2-week culture, CDCs from both groups differentiated
into EPCs. After surgical ligation of the LAD, male Hsd:RH-rnu (athymic nude) rats
received: A) 100,000 CDCs (healthy subjects, n=6); B) 100,000 CDCs (patients, n=9); C)
100,000 MNCs (patients, n=9); and D) PBS (control, n=11), by IV injection. Left ventricu-
lar (LV) fibrosis area was assessed histologically, LV function by echocardiography and
pressure parameters, and capillary density by endothelial cell staining.
Results: Four weeks after administration of CDCs, capillary density (mean + SEM) in
ischemic myocardium was significantly greater in group B than in C and D (276.7+15.5 vs
176.4+11.3, and 88.3+5.4/mm2; p<0.01), but less than in A (324.4+52.7/mm2; p<0.05).
LV fibrosis area was significantly reduced in B (17+1.1% vs C: 25.6+2.4%; p<0.05; and
D: 29.8+1.8%; p<0.01), but larger than in A (11.2+2.8%; p<0.05). Percent decline in frac-
tional shortening was significantly less marked in B than in C and D (-26.4+3.2 vs -
45+5.5, and –55.5+2.6%; p<0.01). Regional wall motion score was significantly better in
B than in C and D (2994+143 vs 1639+139, and 1681+108 mmHg/sec; p<0.01).Conclu-
sions: CD34+ cells transplanted from patients with myocardial ischemia achieve thera-
peutic neovascularization leading to myocardial salvage (as demonstrated by inhibition of
LV fibrosis) and preservation of LV function after MI. These findings suggest the possible
use of cell therapy strategies in the treatment of patients with MI.
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1105-168 Gender Differences in the Identification of Patients With 
Coronary Artery Disease by Brachial Artery Ultrasound
Ayan R. Patel, Jeffrey T. Kuvin, Kathleen A. Sliney, William M. Rand, Natesa G. Pandian, 
Richard H. Karas, Tufts-New England Medical Center, Boston, MA
Background. Brachial artery ultrasound (BAU) is a noninvasive method of assessing
endothelial function. Since endothelial dysfunction is present in patients with atheroscle-
rosis, BAU may be a useful screening tool for identifying patients with subclinical coro-
nary artery disease (CAD). Prior studies of predominantly male populations have shown
that BAU is a highly sensitive technique for detecting individuals with CAD. However, the
ability of BAU to identify women with CAD has not been evaluated. This study aimed to
compare the ability of BAU to detect CAD in women versus men. Methods. 209 outpa-
tients (141 women, 68 men) who were either referred for clinically-indicated sestamibi
stress testing, or had a history of angiographically-proven CAD, underwent BAU under
standard conditions. Flow-mediated vasodilation (FMD) was defined as the percent
change in brachial artery diameter during reactive hyperemia compared to baseline. CAD
was defined as an abnormal sestamibi scan (confirmed by prior or subsequent angiogra-
phy), or history of angiographically-documented CAD. Receiver operator characteristic
(ROC) curve analysis was performed to analyze sensitivity and specificity of FMD for
detection of CAD in women and men. Results. Mean age was similar for women and
men with CAD. FMD was higher in the 33 women with CAD (9.1±0.8% (mean ± SEM))
compared to the 31 men with CAD (6.4±0.5%; p=0.008). The FMD cut-point which maxi-
mized sensitivity with the least effect on specificity for identification of CAD in women was
an FMD>=15% (91% sensitivity, 25% specificity). In contrast, the 'optimal' cutpoint in
men was an FMD>=10% (90% sensitivity, 43% specificity), consistent with prior pub-
lished work. If the FMD cutpoint of >=10% defined in men were used to screen women,
BAU would fail to diagnose 42% of the CAD cases in women. Conclusion. BAU can be a
highly sensitive technique for detection of CAD in both men and women. However, mean
FMD is significantly higher in women with CAD than men with CAD, and thus a signifi-
cantly higher FMD cut-point must be used to identify women with CAD. These findings
indicate that, in studies using FMD to evaluate cardiovascular risk, different standards
should be applied for women and men.
1105-169 Vascular Endothelin-1 Activity Correlates With Low-
Density Lipoprotein Cholesterol Levels, but Not With 
Insulin Sensitivity in Hypercholesterolemic Patients
Umberto Campia, Gail Sullivan, Melissa B. Bryant, Carmine Cardillo, Michael J. Quon, 
Julio A. Panza, National Institutes of Health, Bethesda, MD
Background: Patients with hypercholesterolemia have an increased vascular endothelin
(ET-1) activity, which is likely related to an enhanced production of ET-1. In vitro studies
have demonstrated that oxidized LDL may induce ET-1 release in cultured human endot-
helial cells. However, other stimuli, such as insulin, have also been shown to promote ET-
1 synthesis in vitro. The exact mechanisms contributing to the increased ET-1 activity of
hypercholesterolemic patients (HCs) in vivo have not been identified. Thus, we aimed to
determine the contribution of different metabolic parameters to ET-1 activity in resistance
vessels of patients with hypercholesterolemia.
Methods: Twentyfour normotensive HCs and 26 normal controls (NCs) took part in the
study. Forearm blood flow (FBF) responses to intraarterial infusion of the ETA receptor
blocker BQ-123 (100 nmol/min for 60 min) were analyzed by venous occlusion plethys-
mography, and insulin sensitivity (SIClamp) was measured by euglycemic clamp.
Results: As previously shown, BQ-123 administration did not result in significant
changes in FBF from baseline in NCs (P=0.589), whereas it produced significant vasodi-
lation in HCs (P=0.037). In HCs, the response to ETA blockade was significantly corre-
lated with total cholesterol (R=0.441; P=0.031), and LDL-cholesterol (R=0.577;
P=0.003), whereas no significant correlations were observed with basal plasma insulin,
SIClamp, and body mass index (BMI) (all P=NS). No significant correlations between the
response to ETA blockade and total cholesterol, LDL-cholesterol, basal insulin, SIClamp,
and BMI were observed in NCs (all P=NS).
Conclusions: In hypercholesterolemic patients, vascular ET-1 activity is significantly cor-
related with total and LDL-cholesterol plasma levels, but not with other metabolic param-
eters. Our findings indicate that, in this population, the enhanced ET-1 vasoconstrictor
tone is mainly secondary to the increased cholesterol levels, and suggest that choles-
terol-lowering therapy may be effective in reducing ET-1 activity in the vasculature of
patients with primary hypercholesterolemia.
